ENOS Glu298Asp G T and Cardiovascular Disease

The Big Heart Disease Lie

Alternative Treatments for Cardiovascular Disease

Get Instant Access

Associations with the Glu298Asp polymorphism and cardiovascular disease have been reported in many studies (95,96), The Asp298 polymorphism has been shown to have significantly higher (P = 0.001) median plasma NOx than those without this mutation (97). How this reflects NO levels in the vasculature is unclear.

Leeson et al. (98) studying vascular function by endothelium-dependent, flow-mediated brachial artery dilatation (FMD) and endothelium-independent dilatation response to glyceryl trinitrate observed that vascular function was lower in Asp298 carriers, particularly in smokers and that n-3 fatty acids had a positive effect in this group, but not in Glu298 homozygotes.

Not all studies have shown positive associations: Nassar et al. (99) examined the prevalence of this polymorphism in patients with early-onset coronary artery disease (CAD) compared with those manifesting CAD later in life and found no association of the eNOS Asp298 allele with premature CAD, no association was found in a Taiwanese population (100), or a Finnish population (101).

Was this article helpful?

0 0
Your Heart and Nutrition

Your Heart and Nutrition

Prevention is better than a cure. Learn how to cherish your heart by taking the necessary means to keep it pumping healthily and steadily through your life.

Get My Free Ebook


Post a comment